#clinical trial — Friday, August 21, 2026 (2 items)
| 8 | 💬 0 |
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.
(linkinghub.elsevier.com)
|
The Lancet 2026-08-21 | #dermatitis #clinical trial #immunotherapy #inflammation #autoimmune | |
| 0 | 💬 0 |
Informed Consent in an International Trial of Stress Ulcer Prophylaxis: Patterns and Predictors.
(ovid.com)
|
Critical Care Medicine 2026-08-21 | #clinical trial #informed-consent #ethics #critical-care |